T1	PROC 26 47	tratamiento combinado
#1	AnnotatorNotes T1	C0009429; Combined Modality Therapy; Therapeutic or Preventive Procedure
T2	CHEM 52 66	ciclosporina A
#2	AnnotatorNotes T2	C0010592; cyclosporine; Amino Acid, Peptide, or Protein · Pharmacologic Substance
T3	CHEM 69 93	micofenolato de mofetilo
#3	AnnotatorNotes T3	C0209368; mycophenolate mofetil; Organic Chemical · Pharmacologic Substance
T4	DISO 110 149	glomeruloesclerosis segmentaria y focal
#4	AnnotatorNotes T4	C0017668; Focal glomerulosclerosis; Disease or Syndrome
T5	CHEM 150 162	ciclosporina
#5	AnnotatorNotes T5	C0010592; cyclosporine; Amino Acid, Peptide, or Protein · Pharmacologic Substance
T6	CHEM 452 455	CsA
#6	AnnotatorNotes T6	C0010592; cyclosporine; Amino Acid, Peptide, or Protein · Pharmacologic Substance
T7	CHEM 206 220	ciclosporina A
#7	AnnotatorNotes T7	C0010592; cyclosporine; Amino Acid, Peptide, or Protein · Pharmacologic Substance
T8	CHEM 222 225	CsA
#8	AnnotatorNotes T8	C0010592; cyclosporine; Amino Acid, Peptide, or Protein · Pharmacologic Substance
T9	CHEM 229 249	micofenolato mofetil
#9	AnnotatorNotes T9	C0209368; mycophenolate mofetil; Organic Chemical · Pharmacologic Substance
T10	CHEM 251 254	MMF
#10	AnnotatorNotes T10	C0209368; mycophenolate mofetil; Organic Chemical · Pharmacologic Substance
T11	DISO 384 423	glomeruloesclerosis segmentaria y focal
#11	AnnotatorNotes T11	C0017668; Focal glomerulosclerosis; Disease or Syndrome
T12	DISO 557 560	GSF
#12	AnnotatorNotes T12	C0017668; Focal glomerulosclerosis; Disease or Syndrome
T13	DISO 627 630	GSF
#13	AnnotatorNotes T13	C0017668; Focal glomerulosclerosis; Disease or Syndrome
T14	DISO 349 367	síndrome nefrótico
#14	AnnotatorNotes T14	C0027726; Nephrotic Syndrome; Disease or Syndrome
T15	PROC 1205 1207	FG
#15	AnnotatorNotes T15	C0017654; Glomerular Filtration Rate; Diagnostic procedure
T16	CHEM 437 447	esteroides
#16	AnnotatorNotes T16	C0038317; Steroids; Organic Chemical · Pharmacologic Substance
T17	CHEM 531 534	CsA
#17	AnnotatorNotes T17	C0010592; cyclosporine; Amino Acid, Peptide, or Protein · Pharmacologic Substance
T18	CHEM 537 540	MMF
#18	AnnotatorNotes T18	C0209368; mycophenolate mofetil; Organic Chemical · Pharmacologic Substance
T19	CHEM 574 588	ciclosporina A
#19	AnnotatorNotes T19	C0010592; cyclosporine; Amino Acid, Peptide, or Protein · Pharmacologic Substance
T20	CHEM 644 647	CsA
#20	AnnotatorNotes T20	C0010592; cyclosporine; Amino Acid, Peptide, or Protein · Pharmacologic Substance
T21	PROC 659 670	tratamiento
#21	AnnotatorNotes T21	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T22	CHEM 704 707	MMF
#22	AnnotatorNotes T22	C0209368; mycophenolate mofetil; Organic Chemical · Pharmacologic Substance
T23	PROC 739 750	seguimiento
#23	AnnotatorNotes T23	C1522577; Follow up; Health Care Activity | C0420316; Other follow-up; Health Care Activity
T24	PROC 1294 1307	función renal
#24	AnnotatorNotes T24	C0022662; Kidney Function Test; Laboratory Procedure | C2711919; Measurement of renal function; Diagnostic Procedure
T25	DISO 856 867	proteinuria
#25	AnnotatorNotes T25	C0033687; Proteinuria; Finding
T26	PROC 957 968	tratamiento
#26	AnnotatorNotes T26	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T27	DISO 1422 1438	enfermedad renal
#27	AnnotatorNotes T27	C0022658; Kidney Diseases; Disease or Syndrome
T28	ANAT 1530 1548	gastrointestinales
#28	AnnotatorNotes T28	C0012240; Gastrointestinal system; Body System
T29	DISO 1120 1131	proteinuria
#29	AnnotatorNotes T29	C0033687; Proteinuria; Finding
T30	PROC 1486 1497	seguimiento
#30	AnnotatorNotes T30	C1522577; Follow up; Health Care Activity | C0420316; Other follow-up; Health Care Activity
T31	DISO 1513 1548	efectos adversos gastrointestinales
T32	DISO 1579 1593	nefrotoxicidad
#31	AnnotatorNotes T32	C0595916; Toxic nephropathy; Injury or Poisoning
T33	CHEM 1698 1710	hipotensores
#32	AnnotatorNotes T33	C0003364; Antihypertensive Agents; Pharmacologic Substance
T34	PROC 1735 1746	tratamiento
#33	AnnotatorNotes T34	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T35	CHEM 1796 1808	ciclosporina
#34	AnnotatorNotes T35	C0010592; cyclosporine; Amino Acid, Peptide, or Protein · Pharmacologic Substance
T36	PROC 1813 1824	tratamiento
#35	AnnotatorNotes T36	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T37	CHEM 1843 1846	CsA
#36	AnnotatorNotes T37	C0010592; cyclosporine; Amino Acid, Peptide, or Protein · Pharmacologic Substance
T38	CHEM 1849 1852	MMF
#37	AnnotatorNotes T38	C0209368; mycophenolate mofetil; Organic Chemical · Pharmacologic Substance
T39	DISO 1920 1931	proteinuria
#38	AnnotatorNotes T39	C0033687; Proteinuria; Finding
T40	DISO 1779 1782	GSF
#39	AnnotatorNotes T40	C0017668; Focal glomerulosclerosis; Disease or Syndrome
T41	DISO 97 105	enfermos
#40	AnnotatorNotes T41	C0012634; Disease; Disease or Syndrome
T42	DISO 371 379	enfermos
#41	AnnotatorNotes T42	C0012634; Disease; Disease or Syndrome
T43	PROC 468 513	Analizar la eficacia y el perfil de seguridad
#42	AnnotatorNotes T43	C0511730; Identify product efficacy and safety issues; Health Care Activity
T44	DISO 544 552	enfermos
#43	AnnotatorNotes T44	C0012634; Disease; Disease or Syndrome
T45	DISO 614 622	enfermos
#44	AnnotatorNotes T45	C0012634; Disease; Disease or Syndrome
T46	CHEM 675 678	CsA
#45	AnnotatorNotes T46	C0010592; cyclosporine; Amino Acid, Peptide, or Protein · Pharmacologic Substance
T47	DISO 828 836	enfermos
#46	AnnotatorNotes T47	C0012634; Disease; Disease or Syndrome
T48	ANAT 897 902	renal
#47	AnnotatorNotes T48	C0022646; Kidney; Body Part, Organ, or Organ Component | C1278978; Entire kidney; Body Part, Organ, or Organ Component
T49	DISO 1059 1070	proteinuria
#48	AnnotatorNotes T49	C0033687; Proteinuria; Finding
T50	DISO 1099 1107	enfermos
#49	AnnotatorNotes T50	C0012634; Disease; Disease or Syndrome
T51	ANAT 1302 1307	renal
#50	AnnotatorNotes T51	C0022646; Kidney; Body Part, Organ, or Organ Component | C1278978; Entire kidney; Body Part, Organ, or Organ Component
T52	DISO 1389 1397	enfermos
#51	AnnotatorNotes T52	C0012634; Disease; Disease or Syndrome
T53	ANAT 1433 1438	renal
#52	AnnotatorNotes T53	C0022646; Kidney; Body Part, Organ, or Organ Component | C1278978; Entire kidney; Body Part, Organ, or Organ Component
T54	DISO 1568 1576	enfermos
#53	AnnotatorNotes T54	C0012634; Disease; Disease or Syndrome
T55	DISO 1641 1649	enfermos
#54	AnnotatorNotes T55	C0012634; Disease; Disease or Syndrome
T56	DISO 1766 1774	enfermos
#55	AnnotatorNotes T56	C0012634; Disease; Disease or Syndrome
T57	ANAT 1997 2002	renal
#56	AnnotatorNotes T57	C0022646; Kidney; Body Part, Organ, or Organ Component | C1278978; Entire kidney; Body Part, Organ, or Organ Component
T58	LIVB 591 600	Pacientes
#57	AnnotatorNotes T58	C0030705; Patients; Patient or Disabled Group
T59	Dose 680 687	4 mg/kg
T60	Frequency 687 691	/día
T61	Dose 709 712	2 g
T62	Frequency 712 716	/día
T63	Duration 726 734	12 meses
T64	Duration 764 770	5 años
T65	Duration 905 915	los 5 años
T66	Neg_cue 970 976	ningún
T67	LIVB 977 985	paciente
#58	AnnotatorNotes T67	C0030705; Patients; Patient or Disabled Group
T68	LIVB 1016 1025	pacientes
#59	AnnotatorNotes T68	C0030705; Patients; Patient or Disabled Group
T75	Duration 1600 1611	transitoria
#60	AnnotatorNotes T75	C0205374; Transitory; Temporal Concept
T76	Duration 1719 1731	los 12 meses
T77	Duration 1861 1869	12 meses
T80	PHYS 265 286	efecto inmunosupresor
#61	AnnotatorNotes T80	C0021080; Immunosuppression; Organism Function
T81	PHYS 889 902	función renal
#62	AnnotatorNotes T81	C0232804; Renal function; Organ or Tissue Function
T69	PROC 1661 1683	incremento en la dosis
#63	AnnotatorNotes T69	C1707810; Dose Increased; Therapeutic or Preventive Procedure
T70	PHYS 1989 2002	función renal
#64	AnnotatorNotes T70	C0232804; Renal function; Organ or Tissue Function
A1	Assertion T67 Negated
T71	Neg_cue 1933 1935	no
T72	CONC 1936 1944	modifica
A2	Assertion T72 Negated
#65	AnnotatorNotes T72	C0392747; Changing; Functional Concept (?)
R1	Negation Arg1:T71 Arg2:T72	
T73	Spec_cue 317 323	podría
T74	Observation 336 344	remisión
A3	Assertion T74 Speculated
#66	AnnotatorNotes T74	C0544452; Disease remission; Finding
T78	Observation 995 1012	remisión completa
A4	Assertion T78 Negated
#67	AnnotatorNotes T78	C0677874; In complete remission; Finding
R2	Negation Arg1:T66 Arg2:T67	
R3	Negation Arg1:T66 Arg2:T78	
R4	Experiences Arg1:T67 Arg2:T78	
R5	Combined_with Arg1:T2 Arg2:T3	
R6	Used_for Arg1:T2 Arg2:T1	
R7	Location_of Arg1:T57 Arg2:T70	
R8	Combined_with Arg1:T7 Arg2:T9	
R9	Combined_with Arg1:T8 Arg2:T9	
R10	Combined_with Arg1:T8 Arg2:T10	
R11	Combined_with Arg1:T7 Arg2:T10	
R12	Causes Arg1:T8 Arg2:T80	
R13	Causes Arg1:T7 Arg2:T80	
R14	Before Arg1:T7 Arg2:T74	
R15	Before Arg1:T8 Arg2:T74	
R16	Before Arg1:T14 Arg2:T74	
R17	Combined_with Arg1:T17 Arg2:T18	
R18	Experiences Arg1:T58 Arg2:T45	
R19	Experiences Arg1:T58 Arg2:T13	
R20	Used_for Arg1:T46 Arg2:T21	
R21	Has_Dose_or_Strength Arg1:T46 Arg2:T59	
R22	Has_Frequency Arg1:T46 Arg2:T60	
R23	Combined_with Arg1:T46 Arg2:T22	
R24	Has_Dose_or_Strength Arg1:T22 Arg2:T61	
R25	Has_Frequency Arg1:T22 Arg2:T62	
R26	Has_Duration_or_Interval Arg1:T22 Arg2:T63	
R27	Has_Duration_or_Interval Arg1:T46 Arg2:T63	
R28	Experiences Arg1:T58 Arg2:T46	
R29	Experiences Arg1:T58 Arg2:T20	
R30	Has_Duration_or_Interval Arg1:T23 Arg2:T64	
R31	Before Arg1:T26 Arg2:T78	
R32	Experiences Arg1:T67 Arg2:T26	
T79	Observation 841 849	remisión
#68	AnnotatorNotes T79	C0544452; Disease remission; Finding
R33	Before Arg1:T47 Arg2:T79	
R34	Before Arg1:T25 Arg2:T79	
R35	Location_of Arg1:T48 Arg2:T81	
T82	CONC 873 882	evolución
#69	AnnotatorNotes T82	C0449259; Clinical course; Temporal Concept
R36	Has_Duration_or_Interval Arg1:T82 Arg2:T65	
R37	Overlap Arg1:T82 Arg2:T81	
T83	Observation 163 173	resistente
#70	AnnotatorNotes T83	C3542449; Drug Resistance Status; Finding (?)
R38	Has_Quantifier_or_Qualifier Arg1:T4 Arg2:T83	
R39	Overlap Arg1:T5 Arg2:T83	
R41	Before Arg1:T11 Arg2:T74	
R42	Causes Arg1:T11 Arg2:T14	
#71	AnnotatorNotes R42	(?)
T84	Observation 424 434	resistente
#72	AnnotatorNotes T84	C3542449; Drug Resistance Status; Finding (?)
R43	Has_Quantifier_or_Qualifier Arg1:T11 Arg2:T84	
R44	Overlap Arg1:T84 Arg2:T16	
R45	Overlap Arg1:T84 Arg2:T6	
T85	Observation 561 571	resistente
#73	AnnotatorNotes T85	C3542449; Drug Resistance Status; Finding (?)
R51	Has_Quantifier_or_Qualifier Arg1:T12 Arg2:T85	
R52	Overlap Arg1:T85 Arg2:T19	
R53	Overlap Arg1:T25 Arg2:T81	
R54	Overlap Arg1:T47 Arg2:T81	
R55	Overlap Arg1:T79 Arg2:T81	
R56	Experiences Arg1:T68 Arg2:T49	
R57	Experiences Arg1:T68 Arg2:T26	
T86	Observation 1046 1055	reducción
R58	Experiences Arg1:T68 Arg2:T86	
R59	Before Arg1:T49 Arg2:T86	
T87	Quantifier_or_Qualifier 1132 1137	basal
#74	AnnotatorNotes T87	C1442488; Baseline; Quantitative Concept
R60	Has_Quantifier_or_Qualifier Arg1:T29 Arg2:T87	
R62	Overlap Arg1:T47 Arg2:T25	
R63	Location_of Arg1:T51 Arg2:T24	
T88	Quantifier_or_Qualifier 1308 1313	basal
#75	AnnotatorNotes T88	C1442488; Baseline; Quantitative Concept
R66	Has_Quantifier_or_Qualifier Arg1:T24 Arg2:T88	
T89	Quantifier_or_Qualifier 1439 1449	progresiva
#76	AnnotatorNotes T89	C0205329; Progressive; Functional Concept
R70	Has_Quantifier_or_Qualifier Arg1:T27 Arg2:T89	
R71	Location_of Arg1:T53 Arg2:T27	
T90	Quantifier_or_Qualifier 1452 1461	estadio V
R72	Has_Quantifier_or_Qualifier Arg1:T27 Arg2:T90	
T91	CONC 1465 1497	final del período de seguimiento
R73	Overlap Arg1:T27 Arg2:T91	
R74	Overlap Arg1:T27 Arg2:T30	
R75	Location_of Arg1:T28 Arg2:T31	
R76	Overlap Arg1:T31 Arg2:T54	
T92	Quantifier_or_Qualifier 1594 1599	aguda
#77	AnnotatorNotes T92	C0205178; acute; Temporal Concept
R78	Has_Quantifier_or_Qualifier Arg1:T32 Arg2:T92	
R79	Has_Duration_or_Interval Arg1:T32 Arg2:T75	
R83	Has_Duration_or_Interval Arg1:T69 Arg2:T76	
R84	Used_for Arg1:T33 Arg2:T34	
R85	Overlap Arg1:T69 Arg2:T34	
R86	Combined_with Arg1:T37 Arg2:T38	
R87	Has_Duration_or_Interval Arg1:T38 Arg2:T77	
R88	Has_Duration_or_Interval Arg1:T37 Arg2:T77	
R89	Used_for Arg1:T37 Arg2:T36	
T93	Observation 1783 1793	resistente
#78	AnnotatorNotes T93	C3542449; Drug Resistance Status; Finding (?)
R90	Has_Quantifier_or_Qualifier Arg1:T40 Arg2:T93	
R91	Overlap Arg1:T93 Arg2:T35	
T95	CONC 1967 1982	curso evolutivo
#79	AnnotatorNotes T95	C0449259; Clinical course; Temporal Concept
R99	Speculation Arg1:T73 Arg2:T74	
#82	AnnotatorNotes T86	C0547047; Decrease; Quantitative Concept
T97	Quantifier_or_Qualifier 1945 1963	significativamente
A5	Assertion T97 Negated
#83	AnnotatorNotes T97	C0750502; Significant; Idea or Concept
R101	Has_Quantifier_or_Qualifier Arg1:T72 Arg2:T97	
R102	Negation Arg1:T71 Arg2:T97	
R40	Has_Duration_or_Interval Arg1:T34 Arg2:T76	
R46	Overlap Arg1:T56 Arg2:T39	
R47	Overlap Arg1:T40 Arg2:T39	
R48	Overlap Arg1:T50 Arg2:T29	
#80	AnnotatorNotes T31	C1559265; Adverse Event Associated with the Gastrointestinal System; Finding 
A6	Experiencer T58 Patient
A7	Experiencer T67 Patient
A8	Experiencer T68 Patient
